Tissue and serum sialidase levels in breast cancer

Cancer Letters

Volumn 136, Issue 1, 1999, Pages 75-78

  Sonmez H ^a   Suer S ^a   Gungor Z ^a   Baloglu H ^b   Kokoglu E ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Breast cancer; Sialidase; Tumor marker

Indexed keywords

SIALIDASE; TUMOR MARKER;

ARTICLE; BREAST CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; TISSUE LEVEL;

BREAST NEOPLASMS; FEMALE; HUMANS; NEURAMINIDASE; TUMOR MARKERS, BIOLOGICAL;

EID: 0345390284     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00295-X     Document Type: Article

References (29)

1. Alon R., Bayer E.A., Wilchek M. A coupled enyzme assay for measurement of sialidase activity. J. Biochem. Biophys. Methods. 22:1991;23-33.
2. Brozmanova F., Skroriava B. Sialic acid and bone tumors. Neoplasma. 19:1972;116-123.
3. Cohen-Forterre L., Andre J., Mozere G., Peyrouw J., Sternberg M. Kidney sialidase and sialyltransferase activities in spontaneously and experimentally diabetic rats. Biochem. Pharmacol. 40:1990;507-513.
4. Cohen-Forterre L., Mozere G., Andre J., Sternberg M. Studies on kidney sialidase in normal and diabetic rats. Biochim. Biophys. Acta. 801:1984;138-145.
5. Cohen-Forterre L., Grigorova-Borros A.M., Falcy C., Mansour G., Mozere G., Peyroux J., Sternberg M. Alteration of sialidase activity and other glycosidase activities in the kidney of spontaneously hypertensive rats: persistence after preventive treatment with hydralazine. Can. J. Physiol. Pharmacol. 66:1990;884-888.
6. Dnistrian A., Schwart M. Plasma lipid-bound sialic acid and carcinoembryonic antigen in cancer. Clin. Chem. 27:1981;1734-1739.
7. Evans I.M., Hiey R., Murphy M., Bosman B. N-Acetylneuraminic acid transferase activity with growth of the R3230 AL mammary tumor in rats and relationship of the serum activity to tumor burden. Cancer Res. 40:1980;3103-3111.
8. Fingerhut R., Van der Horst G.T.J., Verheijen F., Conzelmann E. Degradation of gangliosides by the lysosomal sialidase requires an activator protein. Eur. J. Biochem. 208:1992;623.
9. Gatchev O., Rastam L., Liudberg G., Gullberg B., Eklund G.A., Tornberg S. Tumours of the central nervous system and serum sialic acid concentration in men and women. Br. J. Cancer. 68:1993;425-527.
10. Gottschalk A., Bhargava A.S. Neuraminidases. Boyer P.D. 3 The Enzymes. 5:1971;321 Academic Press, New York.
11. Henderson C. Breast cancer. Wilson J.D. Harrison's Principles of Internal Medicine. 2:1991;1612 Mc-Graw-Hill, New York. (Int. Ed.).
12. Henderson W., Kessel D. Alteration in plasma sialyltransferase levels in patients with neoplastic disease. Cancer. 38:1977;1129-1134.
13. Horgan J.E. Total and lipid-bound sialic acid in sera from patents with cancer. Clin. Chim. Acta. 1118:1982;327-331.
14. Khanderia U., Keller J., Grossman B. Serum sialic acid is a biological marker for malignant disease. J. Surg. Oncol. 23:1983;163-166.
15. Kokoǧlu E., Sönmez H., Uslu E., Uslu I. Sialic acid levels in various types of cancer. Cancer Biochem. Biophys. 13:1992;57-64.
16. Lowry O.H., Rosebrough N.J., Farr A.C., Randal R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265.
17. Mabry E.W., Carubelli R. Sialic acid in human cancer. Experientia. 28:1972;182-183.
18. Marth E., Flaschka G., Stiegler S., Mose J.R. Sialic acid as a marker for differentiation between benign and malignant intracranial tumors. Clin. Chim. Acta. 176:1988;251-258.
19. Miyagi T., Hata K., Konno K., Tsuiki S. Multiple forms of mammalian sialidase; altered expression in carcinogenesis. Tohoku J. Exp. Med. 168:1992;223-229.
20. Miyagi T., Sagawa J., Kuroki T., Matsuya Y., Tsuiki S. Tumor promoting phorbol ester induces alterations of sialidase and sialyltransferase activities of JB6 cells. Jpn. J. Cancer Res. 81:1990;1286-1292.
21. Reed R.G., Gutterman J.U., Maviigit G.M., Hersh E.M. Sialic acid on leukemia cells: relation to morphology and tumor immunity. Proc. Soc. Exp. Biol. Med. 145:1974;790-793.
22. Ronquist G., Nov E. Serum sialyltransferase and fucosyltransferase activities in patients with bronchial carcinoma. Cancer. 52:1983;1674-1683.
23. Rooney M.T., Henry J.B. Molecular markers of malignant neoplasms. Hery J.B. Clinical Diagnosis and Management by Laboratory Methods. 18 :1991;285 W.B. Saunders, Philadelphia, PA.
24. Schauer R., Sander-Wewer M., Gutschker-Gdaniec G.H.M., Roggentin P., Randow E.A., Hobrecht R. Sialidase activity in the sera of patients and rabbits with clostridial myonecrosis. Clin. Chim. Acta. 145:1985;119-127.
25. Schuter E.M., Visser J.J., Van Kamp G.J., Mensdorff P.S., Van Dijk W., Hilgers J., Kenemans P. The utility of lipid-associated sialic acid as a serum marker for malignancy. Tumor Biol. 13:1992;121-132.
26. Shamberger R.J. Serum sialic acid in normals and in cancer patients. J. Clin. Chem. Clin. Biochem. 22:1984;647-651.
27. Silver H., Rangel D., Mantor D. Serum sialic acid elevations in malignant melanoma patients. Cancer. 41:1978;1497-1499.
28. Singhal A., Hakomori S. Molecular changes in carbohydrate antigens associated with cancer. Bioassays. 12:1990;223-230.
29. Weiss J.F., Morantz R.A., Bradley W.P., Chretien P.B. Serum acute-phase proteins and immunoglobulins in patients with gliomas. Cancer Res. 39:1979;542-544.